Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microsatellite Repeats | 1 | 2018 | 784 | 0.520 |
Why?
|
| Immunotherapy | 6 | 2018 | 4745 | 0.520 |
Why?
|
| Pica | 1 | 2014 | 37 | 0.460 |
Why?
|
| Micronutrients | 1 | 2014 | 390 | 0.370 |
Why?
|
| Zinc | 1 | 2014 | 675 | 0.350 |
Why?
|
| Antigens, Neoplasm | 5 | 2018 | 1997 | 0.320 |
Why?
|
| Hemoglobins | 1 | 2014 | 1531 | 0.300 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2018 | 3186 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8628 | 0.260 |
Why?
|
| Anemia | 1 | 2014 | 1514 | 0.240 |
Why?
|
| Kidney Neoplasms | 2 | 2018 | 4282 | 0.220 |
Why?
|
| Neoplasms | 5 | 2018 | 22350 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2020 | 5332 | 0.210 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 1885 | 0.190 |
Why?
|
| Epitopes | 2 | 2018 | 2526 | 0.180 |
Why?
|
| Mutation | 11 | 2019 | 30211 | 0.170 |
Why?
|
| Uterine Neoplasms | 2 | 2020 | 1424 | 0.160 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 419 | 0.140 |
Why?
|
| Interferons | 2 | 2018 | 716 | 0.140 |
Why?
|
| Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2017 | 50 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2020 | 424 | 0.140 |
Why?
|
| Melanoma | 5 | 2019 | 5702 | 0.140 |
Why?
|
| Genomics | 5 | 2018 | 5924 | 0.130 |
Why?
|
| Introns | 1 | 2018 | 965 | 0.130 |
Why?
|
| Immunologic Surveillance | 1 | 2016 | 92 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3599 | 0.120 |
Why?
|
| DNA Mismatch Repair | 1 | 2018 | 431 | 0.120 |
Why?
|
| Microsatellite Instability | 1 | 2018 | 726 | 0.120 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2015 | 161 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2020 | 854 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2017 | 371 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 557 | 0.110 |
Why?
|
| Hematocrit | 1 | 2014 | 622 | 0.100 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 426 | 0.100 |
Why?
|
| Anus Neoplasms | 1 | 2016 | 336 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 724 | 0.100 |
Why?
|
| Immunity | 1 | 2018 | 1002 | 0.100 |
Why?
|
| Wrist | 1 | 2014 | 231 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 904 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2017 | 1155 | 0.090 |
Why?
|
| Skin Neoplasms | 4 | 2020 | 5859 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 1119 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2020 | 41718 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 3944 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9532 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2020 | 12158 | 0.080 |
Why?
|
| Sarcoma | 1 | 2020 | 1802 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 6360 | 0.080 |
Why?
|
| Hand | 1 | 2014 | 910 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2018 | 3445 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2018 | 6260 | 0.070 |
Why?
|
| Patient Transfer | 1 | 2014 | 788 | 0.070 |
Why?
|
| Carcinoma | 1 | 2017 | 2326 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3076 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 2186 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5794 | 0.060 |
Why?
|
| Orthopedics | 1 | 2014 | 906 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 17097 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2018 | 9245 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3828 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2535 | 0.060 |
Why?
|
| Humans | 24 | 2020 | 767040 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4114 | 0.060 |
Why?
|
| Motivation | 1 | 2014 | 2021 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4405 | 0.050 |
Why?
|
| Antigen Presentation | 2 | 2019 | 1250 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4903 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 13491 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 4049 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3618 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 1105 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3928 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10582 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2020 | 292 | 0.040 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2018 | 73 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2018 | 301 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15851 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2020 | 1677 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11872 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 29963 | 0.030 |
Why?
|
| Male | 11 | 2020 | 364203 | 0.030 |
Why?
|
| Adult | 8 | 2020 | 223317 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 328 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11097 | 0.030 |
Why?
|
| Female | 11 | 2020 | 396660 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 239 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 59548 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 476 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 7871 | 0.030 |
Why?
|
| Middle Aged | 9 | 2020 | 223233 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3073 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2016 | 959 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 1418 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 748 | 0.030 |
Why?
|
| Cystectomy | 1 | 2017 | 603 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1864 | 0.030 |
Why?
|
| Aged | 7 | 2020 | 171319 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 2745 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 30238 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36485 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2014 | 267 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3618 | 0.020 |
Why?
|
| Cisplatin | 1 | 2017 | 1656 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42606 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 789 | 0.020 |
Why?
|
| Mice | 4 | 2020 | 81912 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 59980 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2018 | 1041 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1646 | 0.020 |
Why?
|
| Autophagy | 1 | 2018 | 1347 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2015 | 1334 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6106 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3611 | 0.020 |
Why?
|
| Animals | 5 | 2020 | 168965 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13650 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1758 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4892 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2493 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4539 | 0.020 |
Why?
|
| RNA | 1 | 2018 | 2715 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1893 | 0.020 |
Why?
|
| Disasters | 1 | 2014 | 521 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5891 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6844 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 2902 | 0.020 |
Why?
|
| Child | 1 | 2014 | 80771 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3667 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 89046 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9551 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4780 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13411 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11063 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4426 | 0.010 |
Why?
|
| Genome, Human | 1 | 2016 | 4441 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12823 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3913 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4648 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7446 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11657 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12793 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18330 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65295 | 0.010 |
Why?
|
| Sex Factors | 1 | 2014 | 10622 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10254 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81659 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 9410 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5389 | 0.010 |
Why?
|
| Physicians | 1 | 2014 | 4593 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40154 | 0.010 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(83)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_